Hemodynamic effects of isoprostanes (8-iso-prostaglandin F(2α) and E2) in isolated guinea pig hearts

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 6, 1997, Pages 789-794

  Mobert J ^b   Becker, B F ^a   Zahler, S ^b   Gerlach, E ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Coronary flow; Endothelin 1; Isoprostanes; Lactate; Myocardial contractility; Pyruvate

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; 8 ISOPROSTAGLANDIN E2; 8 ISOPROSTAGLANDIN F2 ALPHA; ENDOTHELIN 1; ISOPROSTANE; LACTIC ACID; PYRUVIC ACID; THROMBOXANE RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY BLOOD FLOW; GUINEA PIG; HEART LEFT VENTRICLE OVERLOAD; HEART PERFUSION; ISOLATED HEART; LIPID PEROXIDATION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; CORONARY CIRCULATION; DINOPROST; DINOPROSTONE; ENDOTHELIN-1; F2-ISOPROSTANES; GUINEA PIGS; HEART RATE; HEMODYNAMIC PROCESSES; HYDRAZINES; ISOPROSTANES; LACTIC ACID; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PYRUVIC ACID; RECEPTORS, THROMBOXANE; VASOCONSTRICTOR AGENTS;

EID: 0030748556     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199706000-00012     Document Type: Article

References (25)

1. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990;8:9383-7.
2. Morrow DJ, Harris TM, Roberts LJ. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem 1990;184: 1-10.
3. 2α, is formed in vivo. Biochim Biophys Acta 1994;1210:244-8.
4. 2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A 1992;89:10721-5.
5. 2α, in pulmonary oxygen toxicity. J Appl Physiol 1994;77:2912-7.
6. 2-isoprostane) metabolites in human urine and plasma. J Biol Chem 1993;268:4161-9.
7. Morrow DJ, Minton TA, Mukundan CR, et al. Free-radical induced generation of isoprostanes in vivo: evidence for the formation of D-rins and E-ring isoprostanes. J Biol Chem 1994;269(suppl 6): 4317-26.
8. 2α, in rabbit lung in situ. Am J Physiol 1992;263(Heart Circ Physiol 32):H660-3.
9. 2-isoprostane. Biochem Biophys Res Commun 1993;195:507-15.
10. 2 receptors. J Clin Invest 1992;90:136-41.
11. 2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins 1992;44:155-63.
12. 2, on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor. Prostaglandins 1994;48:247-56.
13. 2. Adv Prostaglandin Thromboxane Res 1995;23:237-9.
14. Masaki TJ. The discovery, the present state, and the future prospects of endothelin. Cardiovasc Pharmacol 1989;13(suppl 5): S1-4.
15. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vaso-constrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
16. Schwartz LM, Raschke P, Becker B, Gerlach E. Adenosine contributes to neutrophil-mediated loss of myocardial function in post-ischemic guinea-pig hearts. J Mol Cell Cardiol 1993;25:927-38.
17. Seligmann C, Becker BF, Beblo S, Gerlach E. Adenosine as an antagonizing factor of platelet-induced early reperfusion injury [Abstract]. Ann Hematol 1994;69(suppl II):S85.
18. Seligmann C, Becker BF, Kupatt C, Beblo S, Gerlach E. Endogenous adenosine prevents platelet adhesion in the coronary system during early reperfusion, but not during low-flow ischemia [Abstract]. Pflugers Arch 1995;429(suppl 6):R109.
19. 2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 1993;264: C1619-24.
20. Manning A, Singal S, Hearse DJ. Reperfusion-induced arrhythmias in the rat: mechanism and prevention. J Mol Cell Cardiol 1984; 16:497-518.
21. Bolli R, Jeroudi BS, Patel BS, et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy began at the time of reperfusion: evidence that myocardial stunning is a manifestation of reperfusion injury. Circ Res 1989;65:607-22.
22. Meerson FZ, Kagan VE, Kozlov YP, Belkina LM, Arkhipenko YV. The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart. Basic Res Cardiol 1982;77:465-85.
23. Lucchesi BR, Werns SW, Fantone JC. The role of the neutrophil and free radicals in ischemic myocardial injury. J Mol Cell Cardiol 1989;21:1241-51.
24. Hirata Y, Umemura K, Uematsu T, Nakashima M. An experimental myocardial infarction model in the rat and its properties. Jpn J Pharmacol 1995;67(1):51-7.
25. 2 receptor antagonist, in myocardial ischemia-reperfusion injury. Agents Actions 1993;39(3-4):143-9.